Joseph S. Shan
2017
In 2017, Joseph S. Shan earned a total compensation of $510.6K as Former Vice President, Clinical & Regulatory Affairs at Peregrine Pharmaceuticals, a 12% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $87,212 |
|---|---|
| Option Awards | $62,850 |
| Salary | $308,654 |
| Other | $51,913 |
| Total | $510,629 |
Shan received $308.7K in salary, accounting for 60% of the total pay in 2017.
Shan also received $87.2K in non-equity incentive plan, $62.9K in option awards and $51.9K in other compensation.
Rankings
In 2017, Joseph S. Shan's compensation ranked 11,779th out of 14,666 executives tracked by ExecPay. In other words, Shan earned more than 19.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,779 out of 14,666 | 20th |
Division Manufacturing | 4,638 out of 5,772 | 20th |
Major group Chemicals And Allied Products | 1,693 out of 2,075 | 18th |
Industry group Drugs | 1,403 out of 1,731 | 19th |
Industry Pharmaceutical Preparations | 1,096 out of 1,333 | 18th |
Source: SEC filing on August 17, 2018.
Shan's colleagues
We found three more compensation records of executives who worked with Joseph S. Shan at Peregrine Pharmaceuticals in 2017.